Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 903041481b8d17ee-LAX IP: 116.62.10.13 UTC time: 2025-01-16T18:44:07+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4